Rated 9.8 out of 10 in severity, the flaw could allow a remote attacker to gain unauthorized access to applications.

A Franco-German joint venture company – Aurobac Therapeutics – has been formed to try to tackle the rising threat of antimicrobial resistant (AMR) infections. The JV has been formed German pharma ...

bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and ...

Investing.com -- bioMérieux on Thursday cut its full-year 2025 sales forecast after reporting a 25% decline in first-half net income, driven by a large impairment, even as sales and operating margins ...

bioMérieux cuts 2025 sales outlook as profit falls 25% on €146 mln impairment ...

PARIS, France, May 22, 2025 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, today announced a long-term contract renewal and extension ...

Anthropic has announced a new web search tool to its AI chatbot range, Claude, thanks to a new API. Developers will now be able to use the tool to create ‘Claude-powered’ apps that deliver real-time ...

Cybersecurity company Snyk Ltd. today announced the launch of Snyk API & Web, a new dynamic application security testing or DAST solution designed to meet the growing demands of modern and ...

Developing AI agents capable of performing real-time web searches represents a significant advancement in creating systems that deliver accurate, timely, and contextually relevant information. By ...

Sales Growth: 10.3% in 2024, exceeding the revised guidance. Profitability Improvement: 20% increase at constant exchange rates. Free Cash Flow: EUR 330 million, nearly tripling from 2023. SPOTFIRE ...

Good day, and welcome to the bioMérieux Fourth Quarter Sales and Full Year 2024 Results Conference Call. Today's conference is being recorded. At this time, I'd like to turn the conference over to ...

(RTTNews) - QIAGEN N.V. (QGEN) announced that it has filed a complaint against bioMrieux S.A. for patent infringement, reinforcing its commitment to protecting the scientific advancements behind its ...